Clinical Practice Guidelines

SIO is pleased to provide its updated clinical practice guidelines for breast cancer. In June 2018, ASCO announced endorsement of the guidelines. The guidelines were published in 2017. Researchers analyzed which integrative treatments are most effective and safe for patients with breast cancer. The guidelines are a resource for clinicians and patients to inform evidence-based decisions on the use of integrative therapies during breast cancer treatment. Researchers at US and Canadian institutions evaluated the efficacy and safety of more than 80 therapies.

The Journal of the National Cancer Institute Monograph has  published a special issue co-sponsored by SIO, "Advancing the Global Impact of Integrative Oncology"; including a comprehensive definition for integrative oncology. The articles in the special Monograph were all peer-reviewed.

SIO 2019 Conference

On behalf of SIO's executive board, the 2019 conference planning committee, SIO staff, supporters, exhibitors and our partner, Memorial Sloan Kettering Cancer Center Integrative Medicine Service, we want to extend our sincere thanks to the more than 500 people who attended the 16th International Conference October 19-21 in New York City! In addition to record-breaking attendence, SIO2019 also had a record number of abstract submissions, international attendees from 29 countries (this year we welcomed members from two new countries: Spain and Lithuania), a Traditional Chinese Medicine track, a New Investigator track, and a half-day pre-conference program dedicated to advancing evidence-based work in integrative oncology. Thank you for making this year's conference a tremendous success and watch for details about #SIO2020 in the coming weeks and months.